ALKS

ALKERMES PLC

Healthcare | Mid Cap

$0.37

EPS Forecast

$363.5

Revenue Forecast

Announcing earnings for the quarter ending 2025-09-30 soon
SAGESage Therapeutics IncALNYAlnylam Pharmaceuticals IncBMRNBiomarin Pharmaceutical IncIONSIonis Pharmaceuticals IncJAZZJazz Pharmaceuticals PlcNKTRNektar TherapeuticsPAHCPhibro Animal Health CorpRAREUltragenyx Pharmaceutical IncSRPTSarepta Therapeutics Inc